Louise Oni Selected Research

Louise Oni Research Topics

6	Vasculitis (Vasculitides) 12/2023 - 01/2019
6	IgA Vasculitis (Purpura, Schoenlein Henoch) 12/2023 - 01/2019
6	Nephritis 12/2023 - 10/2021
3	Chronic Renal Insufficiency 12/2023 - 01/2022
3	Lupus Nephritis 01/2022 - 06/2016
2	Renal Insufficiency (Renal Failure) 01/2023 - 01/2021
2	Proteinuria 11/2022 - 01/2019
2	Inflammation (Inflammations) 04/2022 - 01/2018
2	Glomerulonephritis 01/2022 - 01/2018
2	Rheumatic Diseases (Rheumatism) 05/2019 - 01/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 12/2023
1	Purpura 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 02/2022
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 01/2022
1	Fibrosis (Cirrhosis) 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Thrombotic Microangiopathies 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 05/2019
1	Infections 01/2019
1	Neoplasms (Cancer) 01/2018
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2018

6	Immunoglobulin A (IgA)IBA 12/2023 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Complement System Proteins (Complement)IBA 12/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 10/2021
2	AutoantibodiesIBA 01/2022 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 05/2019 - 01/2019
1	Bortezomib (Velcade)FDA Link 12/2023
1	Rituximab (Mabthera)FDA Link 12/2023
1	AMG623 peptibodyIBA 12/2023
1	Complement Inactivating AgentsIBA 12/2023
1	ofatumumab FDA Link 12/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	narsoplimabIBA 12/2023
1	Budesonide (Pulmicort)FDA LinkGeneric 12/2023
1	BionIBA 12/2023
1	telitaciceptIBA 12/2023
1	belimumabIBA 12/2023
1	sparsentanIBA 12/2023
1	avacopanIBA 12/2023
1	N 30IBA 01/2023
1	Vancomycin FDA LinkGeneric 02/2022
1	antiglomerular basement membrane antibodyIBA 01/2022
1	Collagen Type IV (Type IV Collagen)IBA 01/2022
1	CreatinineIBA 10/2021
1	Hexosaminidases (Hexosaminidase)IBA 10/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2021
1	AngiotensinogenIBA 10/2021
1	eculizumab FDA Link 01/2020
1	Immunoglobulin G (IgG)IBA 05/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	AngiotensinsIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2016